Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 0AHT0IC02G

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Interleukin-3 receptor subunit alpha binding agent Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1664355-28-5
ChEMBL CHEMBL3990038
FDA SRS 0AHT0IC02G